These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20088742)

  • 1. Pharmacotherapy for end-stage coronary artery disease.
    Sodha NR; Chu LM; Boodhwani M; Sellke FW
    Expert Opin Pharmacother; 2010 Feb; 11(2):207-13. PubMed ID: 20088742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.
    Guo M; Shi JH; Wang PL; Shi DZ
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis for the treatment of inoperable coronary disease: the future.
    Sellke FW; Laham R; Suuronen EJ; Ruel M
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):184-8. PubMed ID: 16959748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis.
    Yuan R; Xin Q; Shi W; Liu W; Lee SM; Hoi P; Li L; Zhao J; Cong W; Chen K
    Cardiovasc Ther; 2018 Oct; 36(5):e12461. PubMed ID: 30035366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors.
    Gatina DZ; Garanina EE; Zhuravleva MN; Synbulatova GE; Mullakhmetova AF; Solovyeva VV; Kiyasov AP; Rutland CS; Rizvanov AA; Salafutdinov II
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial.
    Ruel M; Beanlands RS; Lortie M; Chan V; Camack N; deKemp RA; Suuronen EJ; Rubens FD; DaSilva JN; Sellke FW; Stewart DJ; Mesana TG
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):762-70, 770.e1. PubMed ID: 18374753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis in coronary artery disease: a review of mechanisms and current approaches.
    Narasimhan B; Narasimhan H; Lorente-Ros M; Romeo FJ; Bhatia K; Aronow WS
    Expert Opin Investig Drugs; 2021 Sep; 30(9):947-963. PubMed ID: 34346802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction.
    Boodhwani M; Voisine P; Ruel M; Sodha NR; Feng J; Xu SH; Bianchi C; Sellke FW
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):645-50; discussion 251-2. PubMed ID: 18201892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
    Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.
    Voisine P; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Li J; Malik T; Rosinberg A; Sellke FW
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1414-20. PubMed ID: 15942586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for myocardial angiogenesis.
    Losordo DW; Vale PR; Isner JM
    Am Heart J; 1999 Aug; 138(2 Pt 2):S132-41. PubMed ID: 10426872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis for coronary artery disease.
    Freedman SB; Isner JM
    Ann Intern Med; 2002 Jan; 136(1):54-71. PubMed ID: 11777364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adventitial VEGF(165) gene transfer on vascular thickening after coronary artery balloon injury.
    Pels K; Deiner C; Coupland SE; Noutsias M; Sutter AP; Schultheiss HP; Yla-Herttuala S; Schwimmbeck PL
    Cardiovasc Res; 2003 Dec; 60(3):664-72. PubMed ID: 14659812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
    Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
    Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and overcoming obstacles in angiogenic gene therapy for myocardial ischemia.
    Rubanyi GM
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):109-19. PubMed ID: 24736636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond.
    Giacca M; Zacchigna S
    Gene Ther; 2012 Jun; 19(6):622-9. PubMed ID: 22378343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for coronary artery disease.
    Sim EK; Zhang L; Shim WS; Lim YL; Ge R
    J Card Surg; 2002; 17(4):350-4. PubMed ID: 12546086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease.
    Tio RA; Tan ES; Jessurun GA; Veeger N; Jager PL; Slart RH; de Jong RM; Pruim J; Hospers GA; Willemsen AT; de Jongste MJ; van Boven AJ; van Veldhuisen DJ; Zijlstra F
    J Nucl Med; 2004 Sep; 45(9):1437-43. PubMed ID: 15347709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization.
    Hamawy AH; Lee LY; Crystal RG; Rosengart TK
    Curr Opin Cardiol; 1999 Nov; 14(6):515-22. PubMed ID: 10579070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.